DxTerity is a patient-centric genomics company bringing the power of real-world genomics with From-Home RNA monitoring to improving the management of immune-mediated disease such as autoimmune diseases and cancer. With patented and proprietary technologies that engage patients where they live, DxTerity is increasing clinical study efficiency while transforming the management of immune-mediated disease by helping to provide a more complete picture of an individual’s health. We bring together patients, providers, advocacy groups and researchers, uniting them in a common mission to improve healthcare while enabling patients to live life confidently.